FANCD2 and head and neck cancer: To investigate whether phenylbutyrate may interfere with the FA/BRCA response pathway and block the formation of FANCD2 nuclear foci after cisplatin treatment, the three different head and neck cancer cell lines were treated with phenylbutyrate, cisplatin or the combination of the two agents.